Role of Bcl-2 family proteins (Bax, Bcl-2 and Bcl-X) on cellular susceptibility to radiation in pancreatic cancer cells

European Journal of Cancer

Volumn 35, Issue 9, 1999, Pages 1374-1380

  Lee, J U ^a   Hosotani, R ^a   Wada, M ^a   Doi, R ^a   Kosiba, T ^a   Fujimoto, K ^a   Miyamoto, Y ^a   Tsuji, S ^a   Nakajima, S ^a   Nishimura, Y ^b   Imamura, M ^a  

^a Dept of Surg and Surg Basic Sci ^*  (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cell line; Oncoproteins; Pancreatic cancer; Radiation

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL DEATH; CELL LINE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY;

BLOTTING, WESTERN; HUMANS; MUTATION; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION TOLERANCE; STAINING AND LABELING; TUMOR CELLS, CULTURED;

EID: 0033198110     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00134-3     Document Type: Article

References (26)

1. Ueda N., Shah S.V. Apoptosis. J. Lab. Clin. Med. 124:1994;169-177.
2. Oberhammer F., Wilson J.W., Dive C.et al. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 12:1993;3679-3684.
3. Nakano H., Shinohara K. X-ray-induced cell death. apoptosis and necrosis Radiation Res. 140:1994;1-9.
4. Cain K., Inayat-Hussain S.H., Kokileva L., Cohen G.M. Multi-step DNA cleavage in rat liver nuclei is inhibited by thiol reactive agents. FEBS Lett. 358:1995;255-261.
5. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerated programmed cell death. Cell. 74:1993;609-611.
6. Miyashita T., Harigai M., Hanada M., Reed J.C. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 54:1994;3131-3135.
7. Canman C.E., Gilmer T.M., Coutts S.B., Kastan M.B. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev. 9:1995;600-611.
8. Clarke A.R., Purdie C.A., Harrison D.J.et al. Thymocyte apoptosis induced by p53 dependent and independent pathway. Nature. 362:1993;849-852.
9. Ryan J.J., Danish R., Gottlieb C.A., Clarke M.F. Cell cycle analysis of p53-induced cell death in murine etythroleukemia cells. Mol. Cell. Biol. 13:1993;711-719.
10. Zhan Q., Alamo I., Yu K.et al. The apoptosis associated gamma-ray response of Bcl-X(L) depends on normal p53 function. Oncogene. 13:1996;2287-2293.
11. Olopade O.I., Adeyanju M.O., Safa A.R.et al. Overexpression of Bcl-X protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J. Sci. Am. 3:1997;230-237.
12. Kuhl J.S., Krajewski S., Duran G.E., Reed J.C., Sikic B.I. Spontaneous overexpression of the long form of Bcl-X protein in a highly resistant P388 leukaemia. Br. J. Cancer. 75:1997;268-274.
13. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of human bax gene. Cell. 80:1995;293-299.
14. Pergo P., Giarola M., Righetti S.C.et al. Association between cisplatin resistance and mutation of p53 gene and reduced Bax expression in ovarian carcinoma cell system. Cancer Res. 56:1996;556-562.
15. Lee J.U., Hosotani R., Wada M.et al. Mechanism of apoptosis induced by cisplatin and VP-16 in Panc-1 cells. Anticancer Res. 17:1997;3445-3450.
16. Mori C., Nakamura N., Okamoto Y., Shiota K. Cytochemical identification of programmed cell death in the fusing fetal mouse palate by specific labeling of DNA fragmentation. Anat. Embryol. 190:1994;21-28.
17. Doi R., Wada M., Hosotani R.et al. Role of apoptosis in duct obstruction-induced pancreatic involution in the rats. Pancreas. 14:1997;39-46.
18. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling nuclear DNA fragmentation. J. Cell. Biol. 119:1992;493-501.
19. Wada M., Doi R., Hosotani R.et al. Expression of Bcl-2 and PCNA in ductal cells after pancreatic duct ligation in rats. Pancreas. 15:1997;176-182.
20. Korsmeyer S.J. Bcl-2 initiates a new category of oncogenes. regulators of cell death Blood. 80:1992;879-886.
21. Findley H.W., Gu L., Yeager A.M., Zhou M. Expression and regulation of Bcl-2, Bcl-XL, and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia. Blood. 89:1997;2986-2993.
22. Ludwig R.L., Bates S., Vousden K.H.et al. Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol. Cell. Biol. 16:1996;4952-4960.
23. Shao Z.M., Dawson M.I., Li X.S.et al. p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene. 11:1995;493-504.
24. Wosikowski K., Regis J.T., Robey R.W.et al. Normal p53 status and function despite the development drug resistance in human breast cancer cells. Cell Growth Differ. 6:1995;1395-1403.
25. Pergo P., Giarola M., Righetti S.C.et al. Association between cisplatin resistance and mutation of p53 gene and reduced Bax expression in ovarian carcinoma cell system. Cancer Res. 56:1996;556-562.
26. Han Z., Chatterjee D., He D.M.et al. Evidence for a G2 checkpoint in p53-independent apoptosis induction by X-irradiation. Mol. Cell. Biol. 15:1995;5849-5857.